As of Jun 30
| +0.57 / +0.54%|
The 7 analysts offering 12-month price forecasts for China Biologic Products Inc have a median target of 141.00, with a high estimate of 162.00 and a low estimate of 124.00. The median estimate represents a +32.62% increase from the last price of 106.32.
The current consensus among 7 polled investment analysts is to Buy stock in China Biologic Products Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.